Hjem › Hypertrofisk kardiomyopati › Texas
Hypertrofisk kardiomyopati kliniske forsøg i Texas
4 studier for Hypertrofisk kardiomyopati søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
- LIONHEART-HCM Site 0121, Plano
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 2. okt. 2026 · NCT07755904A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- og 3 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Houston
- Imbria Investigational Site, Plano
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. maj 2026 · NCT07023614Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
- Houston Methodist Hospital, Houston
RekruttererFase 1/2
Alder 18 til 75 · Alle køn · Opdateret 19. mar. 2026 · NCT05836259Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.